Deciphering the resistance mechanism of RET kinase mutant against vandetanib and nintedanib using molecular dynamics simulations

References

• Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell. 1985;42(2):581–588.
   PubMed Web of Science ®Google Scholar
• Borrello MG, Ardini E, Locati LD, et al. RET inhibition: implications in cancer therapy. Expert Opin Ther Targets. 2013;17(4):403–419.
   PubMed Web of Science ®Google Scholar
• Tsuzuki T, Takahashi M, Asai N, et al. Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene. 1995;10(1):191–198.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu Z, You G. Insulin-like growth factor 1 modulates the phosphorylation, expression, and activity of organic anion transporter 3 through protein kinase a signaling pathway. Acta Pharm Sin B. 2020;10(1):186–194.
   PubMed Web of Science ®Google Scholar
• Chi X, Michos O, Shakya R, et al. Ret-dependent cell rearrangements in the Wolffian duct epithelium initiate ureteric bud morphogenesis. Dev Cell. 2009;17(2):199–209.
   PubMed Web of Science ®Google Scholar
• Wang X. Structural studies of GDNF family ligands with their receptors-insights into ligand recognition and activation of receptor tyrosine kinase RET. Biochim Biophys Acta. 2013;1834(10):2205–2212.
   PubMed Web of Science ®Google Scholar
• Drilon A, Hu ZI, Lai GGY, et al. Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes. Nat Rev Clin Oncol. 2018;15(3):150–167.
   PubMed Web of Science ®Google Scholar
• Xiang H, Zhang J, Lin C, et al. Targeting autophagy-related protein kinases for potential therapeutic purpose. Acta Pharm Sin B. 2020;10(4):569–581.
   PubMed Web of Science ®Google Scholar
• Worby CA, Vega QC, Zhao Y, et al. Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J Biol Chem. 1996;271(39):23619–23622.
   PubMed Web of Science ®Google Scholar
• Fukuda T, Kiuchi K, Takahashi M. Novel mechanism of regulation of Rac activity and lamellipodia formation by RET tyrosine kinase. J Biol Chem. 2002;277(21):19114–19121.
   PubMed Web of Science ®Google Scholar
• Zhao K, Guo T, Wang C, et al. Glycoside scutellarin enhanced CD-MOF anchoring for laryngeal delivery. Acta Pharm Sin B. 2020;10(9):1709–1718.
   PubMed Web of Science ®Google Scholar
• Gainor JF, Shaw AT. Novel targets in non-small cell lung cancer: ROS1 and RET fusions. Oncologist. 2013;18(7):865–875.
   PubMed Web of Science ®Google Scholar
• Kato S, Subbiah V, Marchlik E, et al. RET aberrations in diverse cancers: next-generation sequencing of 4,871 patients. Clin Cancer Res. 2017;23(8):1988–1997.
   PubMed Web of Science ®Google Scholar
• Li T, Yan G, Bai Y, et al. Papain bioinspired gold nanoparticles augmented the anticancer potency of 5-FU against lung cancer. J Exp Nanosci. 2020;15(1):109–128.
   Web of Science ®Google Scholar
• Suresh S, Muthukrishnan L, Vennila S, et al. Mechanistic anticarcinogenic efficacy of phytofabricated gold nanoparticles on human lung adenocarcinoma cells. J Exp Nanosci. 2020;15(1):160–173.
   Web of Science ®Google Scholar
• Plaza-Menacho I. Structure and function of RET in multiple endocrine neoplasia type 2. Endocr Relat Cancer. 2018;25(2):T79–90.
   PubMed Web of Science ®Google Scholar
• Knowles PP, Murray-Rust J, Kjaer S, et al. Structure and chemical inhibition of the RET tyrosine kinase domain. J Biol Chem. 2006;281(44):33577–33587.
   PubMed Web of Science ®Google Scholar
• Wells SAJ. Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors. Endocr Relat Cancer. 2018;25(2):T1–13.
   PubMed Web of Science ®Google Scholar
• Mologni L. Development of RET kinase inhibitors for targeted cancer therapy. Curr Med Chem. 2011;18(2):162–175.
   PubMed Web of Science ®Google Scholar
• Terzyan SS, Shen T, Liu X, et al. Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib. J Biol Chem. 2019;294(27):10428–10437.
   PubMed Web of Science ®Google Scholar
• Liu X, Shen T, Mooers BHM, et al. Drug resistance profiles of mutations in the RET kinase domain. Br J Pharmacol. 2018;175(17):3504–3515.
   PubMed Web of Science ®Google Scholar
• Gautschi O, Milia J, Filleron T, et al. Targeting RET in patients with RET-rearranged lung cancers: results from the global, multicenter RET registry. J Clin Oncol. 2017;35(13):1403–1410.
   PubMed Web of Science ®Google Scholar
• Subbiah V, Shen T, Terzyan SS, et al. Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations. Ann Oncol. 2021;32(2):261–268.
   PubMed Web of Science ®Google Scholar
• Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234(3):779–7815.
   PubMed Web of Science ®Google Scholar
• Maier JA, Martinez C, Kasavajhala K, et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11(8):3696–3713.
   PubMed Web of Science ®Google Scholar
• Wang J, Wolf RM, Caldwell JW, et al. Development and testing of a general amber force field. J Comput Chem. 2004;25(9):1157–1174.
   PubMed Web of Science ®Google Scholar
• Feng L, Lu S, Zheng Z, et al. Identification of an allosteric hotspot for additive activation of PPARγ in antidiabetic effects. Sci Bull. 2021;66(15):1559–1570.
   Web of Science ®Google Scholar
• Jorgensen WL, Chandrasekhar J, Madura JD, et al. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79(2):926–935.
   Web of Science ®Google Scholar
• Panchal NK, Bhale A, Verma VK, et al. Computational and molecular dynamics simulation approach to analyze the impact of XPD gene mutation on protein stability and function. Mol Sim. 2020;46(15):1200–1219.
   Web of Science ®Google Scholar
• Vatansever S, Erman B, Gümüş ZH. Comparative effects of oncogenic mutations G12C, G12V, G13D, and Q61H on local conformations and dynamics of K-Ras. Comput Struct Biotechnol J. 2020;18:1000–1011.
   PubMed Web of Science ®Google Scholar
• Wang DD, Yang-Ou L, Xie H, et al. Predicting the impacts of mutations on protein-ligand binding affinity based on molecular dynamics simulations and machine learning methods. Comput Struct Biotechnol J. 2020;18:439–454.
   PubMed Web of Science ®Google Scholar
• Nagarajan H, Vetrivel U. Microsecond scale sampling of Egr-1 conformational landscape to decipher the impact of its disorder regions on structure-function relationship. Mol Sim. 2020;46(16):1255–1264.
   Web of Science ®Google Scholar
• Nie G, Mao Y, Lv Z, et al. Mixed-ligand Cu(II)-containing coordination polymer based on V-shape carboxylate and pyridinyl co-linkers: structural insights, molecular docking and anti-breast cancer activity evolution. J Exp Nanosci. 2019;14(1):160–170.
   Web of Science ®Google Scholar
• Dias FS, Machado WS. Investigation of the thermal conductivity of tetrabenzo[8]circulene (TB8C) by molecular dynamics simulation. Mol Sim. 2021;47(12):1002–1009.
   Web of Science ®Google Scholar
• York DM, Wlodawer A, Pedersen LG, et al. Atomic-level accuracy in simulations of large protein crystals. Proc Natl Acad Sci U S A. 1994;91(18):8715–8718.
   PubMed Web of Science ®Google Scholar
• Lu S, Chen Y, Wei J, et al. Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators. Acta Pharm Sin B. 2021;11(5):1355–1361.
   PubMed Web of Science ®Google Scholar
• Ni D, Wei J, He X, et al. Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy. Chem Sci. 2020;12(1):464–476.
   PubMed Web of Science ®Google Scholar
• Lu S, He X, Yang Z, et al. Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design. Nat Commun. 2021;12(1):4721.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ji D, Lei C, et al. Mechanistic insights into the effect of phosphorylation on Ras conformational dynamics and its interactions with cell signaling proteins. Comput Struct Biotechnol J. 2021;19:1184–1199.
   PubMed Web of Science ®Google Scholar
• Almourfi FM, Singh I, Shoket H, et al. Study of the dynamics of Ceritinib in complex with common variants of anaplastic lymphoma kinase. Mol Sim. 2020;46(18):1467–1473.
   Web of Science ®Google Scholar
• Roe DR, Cheatham TE. 3rd. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 2013;9(7):3084–3095.
   PubMed Web of Science ®Google Scholar
• Han M, Chen LY. Molecular dynamics simulation of human urea transporter B. Mol Sim. 2021;47(12):1022–1028.
   Web of Science ®Google Scholar
• Liang Z, Zhu Y, Long J, et al. Both intra and inter-domain interactions define the intrinsic dynamics and allosteric mechanism in DNMT1s. Comput Struct Biotechnol J. 2020;18:749–764.
   PubMed Web of Science ®Google Scholar
• Jenkins K, Mateeva T, Szabó I, et al. Combining data integration and molecular dynamics for target identification in α-Synuclein-aggregating neurodegenerative diseases: structural insights on synaptojanin-1 (Synj1) . Comput Struct Biotechnol J. 2020;18:1032–1042.
   PubMed Web of Science ®Google Scholar
• Miller BR, 3rd, McGee TDJ, Swails JM, et al. MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput. 2012;8(9):3314–3321.
   PubMed Web of Science ®Google Scholar
• Plaza-Menacho I, Barnouin K, Goodman K, et al. Oncogenic RET kinase domain mutations perturb the autophosphorylation trajectory by enhancing substrate presentation in trans. Mol Cell. 2014;53(5):738–751.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao J, Zhao S, et al. Discovery of 4-arylthiophene-3-carboxylic acid as inhibitor of ANO1 and its effect as analgesic agent. Acta Pharm Sin B. 2021;11(7):1947–1964.
   PubMed Web of Science ®Google Scholar
• Jang H, Zhang M, Nussinov R. The quaternary assembly of KRas4B with Raf-1 at the membrane. Comput Struct Biotechnol J. 2020;18:737–748.
   PubMed Web of Science ®Google Scholar
• Rehman AU, Zhen G, Zhong B, et al. Mechanism of zinc ejection by disulfiram in nonstructural protein 5A. Phys Chem Chem Phys. 2021;23(21):12204–12215.
   PubMed Web of Science ®Google Scholar
• Lu S, Ni D, Wang C, et al. Deactivation pathway of Ras GTPase underlies conformational substates as targets for drug design. ACS Catal. 2019;9(8):7188–7196.
   Web of Science ®Google Scholar
• Li X, Dai J, Ni D, et al. Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B. Int J Biol Macromol. 2020;144:643–655.
   PubMed Web of Science ®Google Scholar
• Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 1995;8(2):127–134.
   PubMedGoogle Scholar
• Li M, Rehman AU, Liu Y, et al. Dual roles of ATP-binding site in protein kinases: orthosteric inhibition and allosteric regulation. Adv Protein Chem Struct Biol. 2021;124:87–119.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Yin X, Li X, et al. Untangling Dual-Targeting therapeutic mechanism of epidermal growth factor receptor (EGFR) based on reversed allosteric communication. Pharmaceutics. 2021;13(5):747.
   PubMed Web of Science ®Google Scholar
• Lu S, Shen Q, Zhang J. Allosteric methods and their applications: facilitating the discovery of allosteric drugs and the investigation of allosteric mechanisms. Acc Chem Res. 2019;52(2):492–500.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Chen Y, Ni D, et al. Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells. Acta Pharm Sin B. 2021. doi:https://doi.org/10.1016/j.apsb.2021.06.015.
   Google Scholar
• Lu S, He X, Ni D, et al. Allosteric modulator discovery: from serendipity to structure-based design. J Med Chem. 2019;62(14):6405–6421.
   PubMed Web of Science ®Google Scholar
• Lu S, Qiu Y, Ni D, et al. Emergence of allosteric drug-resistance mutations: new challenges for allosteric drug discovery. Drug Discov Today. 2020;25(1):177–184.
   PubMed Web of Science ®Google Scholar
• Lu S, Zhang J. Small molecule allosteric modulators of G-protein-coupled receptors: drug-target interactions. J Med Chem. 2019;62(1):24–45.
   PubMed Web of Science ®Google Scholar
• Ni D, Li Y, Pu J, et al. Combining allosteric and orthosteric drugs to overcome drug resistance. Trends Pharmacol Sci. 2020;41(5):336–348.
   PubMed Web of Science ®Google Scholar
• Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983;22(12):2577–2637.
   PubMed Web of Science ®Google Scholar
• Kornev AP, Haste NM, Taylor SS, et al. Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism. Proc Natl Acad Sci U S A. 2006;103(47):17783–17788.
   PubMed Web of Science ®Google Scholar